US Patent Issued to Nanjing GenScript Biotech, Nanjing Legend Biotech on March 25 for "Claudin18.2 binding moieties and uses thereof" (Chinese, Singaporean Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,418, issued on March 25, was assigned to Nanjing GenScript Biotech Co. Ltd. (Nanjing, China) and Nanjing Legend Biotech Co. Ltd (Nanjing, China).

"Claudin18.2 binding moieties and uses thereof" was invented by Liusong Yin (Nanjing, China), Tielin Zhou (Singapore), Zhuo Fang (Nanjing, China), Yong Liu (Nanjing, China), Qiuchuan Zhuang (Nanjing, China), Bo Wu (Nanjing, China), Xiaohu Fan (Nanjing, China), Qingshan Zhang (Nanjing, China), Dan Zhao (Nanjing, China) and Jie Mao (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are binding moieties, such as antibodies, that specifically bind Claudin18.2, and chimeric antigen...